✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Caplin Point Laboratories Ltd.

CAPLIPOINT

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹15,362 Cr.
P/E
27.18

Caplin Point Laboratories Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
15,362 Cr
PE
PE
27.18
Prom Holding
Prom Holding
70.57 %
ROE (%)
ROE (%)
18.81
ROCE (%)
ROCE (%)
23.36
Div Yield (%)
Div Yield (%)
0.30
Sales
Sales
1,988 Cr
OPM (%)
OPM (%)
33.83 %
Debt to Equity
Debt to Equity
0.00
View more
Edit Ratio's

About

Caplin Point Laboratories was established in 1990 to manufacture a range of ointments, creams … Read more
Low
1551
52W Range
High
2636
  • Caplin Point Lab
  • Gufic Biosciences
  • Gland Pharma
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Distribution Channel

Manufacturing Break-Up

Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Caplin Point Laboratories Ltd. Business

    Established in 1990, Caplin Point Laboratories is a mid-sized company in India manufacturing APIs, finished formulations, and engaging in research & development, clinical research, and global marketing.

    Caplin Point Lab major competitors are Gufic Biosciences, Gland Pharma, Natco Pharma, Alembic Pharma, Jubilant Pharmova, Sanofi India, Procter&Gamble Healt.
    Market Cap of Caplin Point Lab is ₹15,334 Crs.
    While the median market cap of its peers are ₹14,838 Crs.

    Caplin Point Lab seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice

    Company Filing

    Discussions & Analysis

    Caplin Point Laboratories Ltd.
    Analysis: Caplin Point Laboratories - Dr Vijay Malik
    View the discussion on ValuePickr
    Data Backed Look At Caplin Steriles - Chins
    Accounting Issues In Caplin Point - ValuePickr
    Pharmaceuticals
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material